Caprion is growing double digits
https://www.genomeweb.com/proteomics/one-year-after-acquisition-caprion-still-eyes-sale-rx-%E2%80%94-no-rush
Homeland deal in itself 13 millions is making Caprion growth = to triple digits.
Now, Caprion is profitable. Caprion has hence an intrinsic value.
Covance will probably buy out Caprion as the business relationship matures.
Probably for 300M and giving 60M to TLN for the 20% equity stake.
Nice....
60M assets sale + a small refinancing of 30 M... TLN will probably be able to move 2 out of the 3 flagship drugs into commercialization.
4601 PII/PIII could be done very fast if endpoint is life expectancy. (15 months)
Shigamabs quite short and sweet trial (15 months)
232 could require more time....